NAFLD

This study tests whether a type 2 diabetes drug (SGLT2 inhibitor) can safely reduce liver fat in adolescents aged 12-20 who have obesity and non-alcoholic fatty liver disease (NAFLD). About 40 participants will receive either the drug or a placebo for several months. The main goa…

This early-stage study will test whether a drug called Henggliejin can improve fatty liver in people who have both type 2 diabetes and nonalcoholic fatty liver disease (NAFLD). About 149 adults will take the drug for 48 weeks, and doctors will check liver health using a simple bl…

This study tests whether adding rutin (a plant compound) to vitamin C can reduce liver fat and inflammation better than vitamin C alone in people with metabolic fatty liver disease (MASLD). About 120 adults will take the supplements for 12 weeks. The goal is to see if this combin…

This study tests whether eating all meals within an 8-hour window each day (time-restricted eating) can help people with fatty liver disease (MASLD) lose weight and reduce liver fat. 150 adults will follow either this eating pattern or standard care for 3 months. Researchers will…

This study looks at whether combining probiotics (good bacteria) with resistance exercise can help people with fatty liver disease. The goal is to reduce liver fat and improve health. 180 adults aged 18-60 with fatty liver will take part. Researchers will also check if the body's…

This study looks at whether a GLP-1 RA drug (used for diabetes and weight loss) can improve fat levels in the liver and blood of people with MASLD (fatty liver disease). About 30 adults with MASLD, diabetes, and obesity will take the drug and have liver biopsies and blood tests t…